Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed, 76011 [2010-30556]

Download as PDF 76011 Federal Register / Vol. 75, No. 234 / Tuesday, December 7, 2010 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Nunber of respondents Item Annual frequency per response Total annual responses Hours per response Total hours MedSun facilities participating in the electronic reporting of adverse events program .................................................. MedSun facilities’ electronic responses to Public Health Questions (PHQs) ............................................................ 400 15 6,000 0.75 4,500 400 10 4,000 0.5 2,000 Total hours .................................................................... ........................ ........................ ........................ ........................ 6,500 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: December 1, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. [FR Doc. 2010–30583 Filed 12–6–10; 8:45 am] Dated: December 1, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. BILLING CODE 4160–01–P [FR Doc. 2010–30556 Filed 12–6–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES [Docket No. FDA–2010–N–0083] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed Food and Drug Administration, HHS. ACTION: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 3793. SUPPLEMENTARY INFORMATION: In the Federal Register of June 18, 2010 (75 FR 34744), the Agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0339. The approval expires on November 30, 2013. A copy of the supporting statement for emcdonald on DSK2BSOYB1PROD with NOTICES VerDate Mar<15>2010 18:39 Dec 06, 2010 Food and Drug Administration [Docket No. FDA–2004–N–0056] (formerly 2004N–0234) Annual Guidance Agenda AGENCY: Jkt 223001 Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: SUPPLEMENTARY INFORMATION: I. Background BILLING CODE 4160–01–P Food and Drug Administration AGENCY: For information regarding specific topics or guidances, please see contact persons or specific offices listed in the table in the SUPPLEMENTARY INFORMATION section of this document. Notice. The Food and Drug Administration (FDA) is publishing its annual guidance document agenda. This list is being published under FDA’s good guidance practices (GGPs) regulations. It is intended to seek public comment on possible topics for future guidance document development or revisions of existing ones. DATES: Submit either electronic or written comments on this list and on any agency guidance document at any time. SUMMARY: Submit electronic comments to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: For general information regarding FDA’s GGP policy contact: Lisa Helmanis, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., WO32, rm. 3216, Silver Spring, MD 20993–0002, 301–796–9135. ADDRESSES: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 In the Federal Register of September 19, 2000 (65 FR 56468), FDA issued its final rule on GGPs (21 CFR 10.115). GGPs are intended to ensure involvement of the public in the development of guidance documents and to enhance understanding of the availability, nature, and legal effect of such guidance documents. As part of FDA’s effort to ensure meaningful interaction with the public regarding guidance documents, the Agency committed to publishing an annual guidance document agenda of possible guidance topics or documents for development or revision during the coming year. The Agency also committed to soliciting public input regarding these and additional ideas for new topics or revisions to existing guidance documents (65 FR 56468 at 56477; 21 CFR 10.115(f)(5)). The Agency is neither bound by this list of possible topics nor required to issue every guidance document on this list or precluded from issuing guidance documents not on the list set forth in this document. The following list of guidance topics or documents represents possible new topics or revisions to existing guidance documents that the Agency is considering. The Agency solicits comments on the topics listed in this document and also seeks additional ideas from the public. The guidance documents are organized by the issuing Center or Office within FDA, and in some cases are further grouped within the issuing Center or Office by topic categories. II. Center for Biologics Evaluation and Research (CBER) E:\FR\FM\07DEN1.SGM 07DEN1

Agencies

[Federal Register Volume 75, Number 234 (Tuesday, December 7, 2010)]
[Notices]
[Page 76011]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30556]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0083]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Substances Prohibited From Use in 
Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Substances Prohibited From Use in 
Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed'' has 
been approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-3793.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 18, 2010 (75 
FR 34744), the Agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0339. 
The approval expires on November 30, 2013. A copy of the supporting 
statement for this information collection is available on the Internet 
at https://www.reginfo.gov/public/do/PRAMain.

    Dated: December 1, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-30556 Filed 12-6-10; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.